Communication Address:

Solara Active Pharma Sciences Limited

2nd Floor, Admin Block

27, Vandaloor Kelambakkam Road, Keelakottaiyur Village, Melakottaiyur (Post) Chennai - 600 127, India

Tel : +91 44 43446700

Fax : +91 44 47406190

E-mail : investors@solara.co.in www.solara.co.in

December 22, 2022

National Stock Exchange of India Limited

Exchange Plaza, Bandra-Kurla Complex

Bandra (E), Mumbai - 400 051

Kind Attn: Mr. Binoy Yohannan

Associate Vice President

Surveillance

Dear Sir,

Sub: Significant increase in volume

Ref: Your letter dated 21.12.2022, with reference: NSE/CM/Surveillance/12640

We refer to your above letter seeking clarification on the significant increase in volume in the securities of the Company across exchanges in the recent past.

We wish to clarify that Company has made all the required disclosures pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and has not withheld any material information/event that, in our opinion, would have a bearing on the price/volume behaviour in the scrip.

Kindly take the same on record.

Thanking you,

Yours faithfully,

For Solara Active Pharma Sciences Limited

SUDDAPALLI MURALIKRISHNA

Digitally signed by SUDDAPALLI MURALIKRISHNA

Date: 2022.12.22 10:22:35 +05'30'

S. Murali Krishna

Company Secretary

Solara Active Pharma Sciences Limited - CIN : L24230MH2017PLC291636

REGD. OFF: 201, Devavrata, Sector 17, Vashi Navi Mumbai - 400703. India/ Tel: 91-22-2789 2924 / 2789 3199 / Fax: 91-22-2789 2942

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Solara Active Pharma Sciences Ltd. published this content on 22 December 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 22 December 2022 05:21:03 UTC.